Theratechnologies Inc. is set to be acquired by CB Biotechnology, a Future Pak affiliate, for approximately $254 million, enhancing Future Pak's biopharmaceutical portfolio.
Information on the Target
Theratechnologies Inc. (TSX: TH, NASDAQ: THTX) is a Canada-based specialty biopharmaceutical company that specializes in the commercialization of innovative therapeutic solutions. The company is dedicated to enhancing patient care by collaborating with academic institutions and industry partners to develop and bring advanced therapeutic products to market. Theratechnologies leverages its substantial expertise in clinical science and regulatory processes, positioning itself as a key player in the biopharmaceutical sector.
The company’s focus on specialized therapies sets it apart in a competitive landscape, allowing it to cater to unmet medical needs in various patient populations. With a commitment to innovation and quality, Theratechnologies strives to deliver effective medicines that improve health outcomes.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Canada
The Canadian biopharmaceutical industry has seen significant growth in recent years, driven by advancements in technology and a robust research environment. The country bo
Similar Deals
FP Partners & Alpha40Capital → Signature Cosmetic Clinics
2025
Sienna Senior Living Inc. → Credit River Retirement Residence
2025
CB Biotechnology
invested in
Theratechnologies Inc.
in 2025
in a Buyout deal
Disclosed details
Transaction Size: $254M